+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Asthma Drugs Market by Product Type, Drug Class, Delivery Mode, Distribution Channel, End Users - Global Forecast to 2030- Product Image
Asthma Drugs Market by Product Type, Drug Class, Delivery Mode, Distribution Channel, End Users - Global Forecast to 2030- Product Image
Sale

Asthma Drugs Market by Product Type, Drug Class, Delivery Mode, Distribution Channel, End Users - Global Forecast to 2030

  • PDF Icon

    Report

  • 194 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5313699
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The asthma therapeutics market is evolving rapidly as clinical innovations, digital integration, and regulatory changes transform treatment options and market dynamics. Industry leaders must adapt to a complex environment shaped by patient-centric models, value-based care, and shifting global supply chains to maintain competitive advantage.

Market Snapshot: Asthma Drugs Market Overview

The Asthma Drugs Market grew from USD 24.30 billion in 2024 to USD 25.75 billion in 2025. It is expected to continue growing at a CAGR of 6.14%, reaching USD 34.75 billion by 2030.

Scope & Segmentation

  • Product Types: Inhalers, nebulizers, tablets, and pills accommodate varying patient needs and routes of administration.
  • Drug Classes: Includes albuterol, beta agonists, bronchodilators, corticosteroids, and leukotriene modifiers, reflecting the layered approach to asthma care.
  • Delivery Modes: Inhalable and oral formats provide flexibility for acute or long-term disease management.
  • Distribution Channels: Hospital pharmacies, online pharmacies, and retail pharmacies ensure a mix of acute intervention and ongoing patient support.
  • End Users: Ambulatory surgery centers, home care, and hospitals & clinics each shape demand for specific product attributes and service models.
  • Regional Coverage: Americas, Europe, Middle East, Africa, and Asia-Pacific markets characterized by distinct payer systems, regulatory landscapes, and adoption rates.
  • Leading Companies: Industry leaders and innovators include ALK-Abelló A/S, AstraZeneca PLC, Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Dr. Reddy’s Laboratories Ltd, Novartis AG, Pfizer Inc., Sanofi S.A., and several others, each bringing unique capabilities to segment leadership and technological integration.

Key Takeaways for Decision-Makers

  • Therapy portfolios are expanding to address rising disease prevalence and the demand for more personalized asthma interventions.
  • Biologic therapies and connected inhalers are disrupting traditional treatment paradigms, with greater precision targeting and outcome tracking.
  • Digital health solutions, including adherence monitoring and remote care, are integral to patient engagement and improved real-world results.
  • Value-based reimbursement and outcome-driven contracts increasingly guide launch strategies, forging closer manufacturer-payer-provider collaboration.
  • Generics and biosimilars attract attention in volume-driven segments, while premium brands differentiate through device innovation and added support programs.
  • Regional differences require customized commercialization, pricing, and supply chain approaches to align with regulatory and payer diversity.

Impact of U.S. Tariffs on Asthma Drugs

Recent U.S. tariffs on imported pharmaceutical ingredients and finished dosage forms have driven up raw material costs for asthma drug manufacturers with global supply chains. These pressures have encouraged a swift evaluation of sourcing strategies, with some stakeholders accelerating efforts to localize production or secure favorable long-term contracts. However, such shifts involve new capital outlays and regulatory processes, extending approval timelines and necessitating nuanced inventory and procurement decisions. The evolving tariff landscape underscores the importance of adaptive supply chain management and cost control, particularly for stakeholders serving price-sensitive or underinsured patient populations.

Methodology & Data Sources

This research utilizes a robust mixed-method approach, combining primary interviews with industry stakeholders and in-depth secondary analysis of peer-reviewed journals, regulatory filings, and proprietary data sources. Data triangulation and peer review by subject-matter experts enhance the accuracy and reliability of all strategic recommendations.

Why This Report Matters

  • Enables senior leaders to anticipate industry evolution and optimize portfolios by leveraging actionable insights on emerging therapies, technology, and commercial models.
  • Supports risk mitigation with timely analysis of regulatory and tariff developments, ensuring operational and supply chain resilience.
  • Equips teams to tailor regional market access and patient engagement strategies for maximum competitive advantage.

Conclusion

The asthma drugs market presents diverse opportunities for growth and innovation, driven by ongoing scientific, technological, and operational advances. Strategic alignment across product, market, and supply chain is essential for sustained leadership.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Asthma Drugs Market, by Product Type
8.1. Introduction
8.2. Inhalers
8.3. Nebulizers
8.4. Tablets & Pills
9. Asthma Drugs Market, by Drug Class
9.1. Introduction
9.2. Albuterol
9.3. Beta Agonists
9.4. Brochodilators
9.5. Corticosteroids
9.6. Leukotriene Modifiers
10. Asthma Drugs Market, by Delivery Mode
10.1. Introduction
10.2. Inhalable
10.3. Oral
11. Asthma Drugs Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacies
11.3. Online Pharmacies
11.4. Retail Pharmacies
12. Asthma Drugs Market, by End Users
12.1. Introduction
12.2. Ambulatory Surgery Centers
12.3. Home Care Settings
12.4. Hospitals & Clinics
13. Americas Asthma Drugs Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Asthma Drugs Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Asthma Drugs Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. ALK-Abelló A/S
16.3.2. Amphastar Pharmaceuticals, Inc.
16.3.3. AstraZeneca PLC
16.3.4. Bayer AG
16.3.5. Boehringer Ingelheim International GmbH
16.3.6. CHIESI Farmaceutici S.p.A.
16.3.7. Cipla Limited
16.3.8. Dr.Reddy’s Laboratories Ltd
16.3.9. F. Hoffmann-La Roche Ltd.
16.3.10. GlaxoSmithKline PLC
16.3.11. Hetero Labs Limited
16.3.12. Lallemand Inc.
16.3.13. Merck KGaA
16.3.14. Mundipharma International Limited
16.3.15. NIOX Group PLC
16.3.16. Novartis AG
16.3.17. Novo Holdings
16.3.18. OPKO Health, Inc.
16.3.19. Pfizer Inc.
16.3.20. Sanner GmbH
16.3.21. Sanofi S.A.
16.3.22. Sunovion Pharmaceuticals Inc.
16.3.23. Teva Pharmaceutical Industries Ltd.
16.3.24. Verona Pharma PLC
16.3.25. Viatris, Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. ASTHMA DRUGS MARKET MULTI-CURRENCY
FIGURE 2. ASTHMA DRUGS MARKET MULTI-LANGUAGE
FIGURE 3. ASTHMA DRUGS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ASTHMA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ASTHMA DRUGS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL ASTHMA DRUGS MARKET SIZE, BY END USERS, 2024 VS 2030 (%)
FIGURE 16. GLOBAL ASTHMA DRUGS MARKET SIZE, BY END USERS, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASTHMA DRUGS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. ASTHMA DRUGS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ASTHMA DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ASTHMA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ASTHMA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ASTHMA DRUGS MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ASTHMA DRUGS MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ASTHMA DRUGS MARKET SIZE, BY TABLETS & PILLS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ALBUTEROL, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ASTHMA DRUGS MARKET SIZE, BY BETA AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ASTHMA DRUGS MARKET SIZE, BY BROCHODILATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ASTHMA DRUGS MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ASTHMA DRUGS MARKET SIZE, BY LEUKOTRIENE MODIFIERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ASTHMA DRUGS MARKET SIZE, BY INHALABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ASTHMA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ASTHMA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ASTHMA DRUGS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ASTHMA DRUGS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 34. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 35. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES ASTHMA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 39. CANADA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 40. CANADA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 41. CANADA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 42. CANADA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 43. CANADA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 44. MEXICO ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 45. MEXICO ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 46. MEXICO ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 47. MEXICO ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 48. MEXICO ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 49. BRAZIL ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 54. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 55. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 56. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 57. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 58. ARGENTINA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 61. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 62. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 66. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 67. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 68. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. UNITED KINGDOM ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 70. GERMANY ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 71. GERMANY ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 72. GERMANY ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 73. GERMANY ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 74. GERMANY ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 75. FRANCE ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 76. FRANCE ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 77. FRANCE ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 78. FRANCE ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 79. FRANCE ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 80. RUSSIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 81. RUSSIA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 82. RUSSIA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 83. RUSSIA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 84. RUSSIA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 85. ITALY ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. ITALY ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 87. ITALY ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 88. ITALY ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. ITALY ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 90. SPAIN ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 91. SPAIN ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 92. SPAIN ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 93. SPAIN ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 94. SPAIN ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 95. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 96. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 97. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 98. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. UNITED ARAB EMIRATES ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 100. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 101. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 102. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 103. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 104. SAUDI ARABIA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 105. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 106. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 107. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 108. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. SOUTH AFRICA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 110. DENMARK ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 111. DENMARK ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 112. DENMARK ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 113. DENMARK ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. DENMARK ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 115. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 116. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 117. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 118. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. NETHERLANDS ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 120. QATAR ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 121. QATAR ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 122. QATAR ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 123. QATAR ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 124. QATAR ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 125. FINLAND ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 126. FINLAND ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 127. FINLAND ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 128. FINLAND ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. FINLAND ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 130. SWEDEN ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. SWEDEN ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 135. NIGERIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 136. NIGERIA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 137. NIGERIA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 138. NIGERIA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 139. NIGERIA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 140. EGYPT ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 141. EGYPT ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 142. EGYPT ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 143. EGYPT ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 144. EGYPT ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 145. TURKEY ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 146. TURKEY ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 147. TURKEY ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 148. TURKEY ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 149. TURKEY ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 150. ISRAEL ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 151. ISRAEL ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 152. ISRAEL ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 153. ISRAEL ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. ISRAEL ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 155. NORWAY ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 156. NORWAY ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 157. NORWAY ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 158. NORWAY ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. NORWAY ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 160. POLAND ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 161. POLAND ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 162. POLAND ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 163. POLAND ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. POLAND ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 165. SWITZERLAND ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 166. SWITZERLAND ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 167. SWITZERLAND ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 168. SWITZERLAND ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 169. SWITZERLAND ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 170. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 171. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 172. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 173. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 174. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 175. ASIA-PACIFIC ASTHMA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 176. CHINA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 177. CHINA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 178. CHINA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 179. CHINA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 180. CHINA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 181. INDIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 182. INDIA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 183. INDIA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 184. INDIA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 185. INDIA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 186. JAPAN ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 187. JAPAN ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 188. JAPAN ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 189. JAPAN ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. JAPAN ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 191. AUSTRALIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 192. AUSTRALIA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 193. AUSTRALIA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 194. AUSTRALIA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 195. AUSTRALIA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 196. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 198. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 199. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. SOUTH KOREA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 201. INDONESIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 202. INDONESIA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 203. INDONESIA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 204. INDONESIA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 205. INDONESIA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 206. THAILAND ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 207. THAILAND ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 208. THAILAND ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 209. THAILAND ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. THAILAND ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 211. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 212. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 213. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 214. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 215. PHILIPPINES ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 216. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 217. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 218. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 219. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. MALAYSIA ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 221. SINGAPORE ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 222. SINGAPORE ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 223. SINGAPORE ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 224. SINGAPORE ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 225. SINGAPORE ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 226. VIETNAM ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 227. VIETNAM ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 228. VIETNAM ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 229. VIETNAM ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 230. VIETNAM ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 231. TAIWAN ASTHMA DRUGS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 232. TAIWAN ASTHMA DRUGS MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
TABLE 233. TAIWAN ASTHMA DRUGS MARKET SIZE, BY DELIVERY MODE, 2018-2030 (USD MILLION)
TABLE 234. TAIWAN ASTHMA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 235. TAIWAN ASTHMA DRUGS MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
TABLE 236. ASTHMA DRUGS MARKET SHARE, BY KEY PLAYER, 2024
TABLE 237. ASTHMA DRUGS MARKET, FPNV POSITIONING MATRIX, 2024

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Asthma Drugs market report include:
  • ALK-Abelló A/S
  • Amphastar Pharmaceuticals, Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • CHIESI Farmaceutici S.p.A.
  • Cipla Limited
  • Dr.Reddy’s Laboratories Ltd
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Hetero Labs Limited
  • Lallemand Inc.
  • Merck KGaA
  • Mundipharma International Limited
  • NIOX Group PLC
  • Novartis AG
  • Novo Holdings
  • OPKO Health, Inc.
  • Pfizer Inc.
  • Sanner GmbH
  • Sanofi S.A.
  • Sunovion Pharmaceuticals Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Verona Pharma PLC
  • Viatris, Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 25.75 Billion
Forecasted Market Value ( USD ) by 2030 $ 34.75 Billion
Compound Annual Growth Rate6.1%
Regions CoveredGlobal
No. of Companies Mentioned26

Related Topics

Related Reports

Asthma Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type - Product Image

Asthma Drugs Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Product Type

  • Report
  • 105 Pages
  • Global
From
Asthma Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030) - Product Image

Asthma Drugs - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)

  • Report
  • 196 Pages
  • Global
From
Asthma Drugs Market Report 2025 - Product Image

Asthma Drugs Market Report 2025

  • Report
  • 200 Pages
  • Global
From
2025 Global Forecast for Asthma Drugs Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Asthma Drugs Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From
2025 Global Forecast for Anti-Asthma Drugs Market (2026-2031 Outlook)-High Tech Outlook Report - Product Image

2025 Global Forecast for Anti-Asthma Drugs Market (2026-2031 Outlook)-High Tech Outlook Report

  • Report
  • 132 Pages
  • Global
From

About the Asthma Treatment Market

The Asthma Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of medications used to treat asthma. Asthma is a chronic respiratory condition that affects the airways, causing difficulty breathing, coughing, and wheezing. Asthma drugs are designed to reduce inflammation in the airways, making it easier for patients to breathe. These drugs can be taken orally, inhaled, or injected, depending on the severity of the condition. Common asthma drugs include corticosteroids, bronchodilators, and leukotriene modifiers. Some of the major companies in the Asthma Drugs market include GlaxoSmithKline, Merck & Co., Novartis, Pfizer, and Sanofi. These companies are involved in the research, development, and marketing of asthma drugs, as well as the production of generic versions of existing drugs. They also provide support services to patients, such as educational materials and access to specialists. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.